Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$144,453,146
+$15,612,933 QoQ
Shares Held
1,124,149
+5.0% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#171
of 3,769 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $1,229,733,122 across 9 Drug Manufacturers - General names. MRK ranks #4 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
244,861 | $293,693,653 | |
| 2 | JNJ |
Johnson & Johnson
|
1,050,526 | $266,802,088 | |
| 3 | ABBV |
AbbVie Inc.
|
907,363 | $228,328,825 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
1,124,149 | $144,453,146 | |
| 5 | AMGN |
Amgen Inc
|
238,092 | $86,217,875 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,167,476 | $67,269,967 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
528,600 | $66,783,324 | |
| 8 | PFE |
Pfizer Inc
|
2,154,713 | $51,885,489 |
All Filings in MRK
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $144,453,146 | 1,124,149 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $128,840,213 | 1,071,080 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $105,754,616 | 1,004,699 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $76,254,097 | 908,544 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $61,620,202 | 778,426 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $68,623,853 | 764,526 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $72,753,106 | 731,334 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $96,372,580 | 848,649 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $88,065,501 | 711,353 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $128,785,443 | 976,017 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $86,611,593 | 794,456 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $90,853,375 | 882,500 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $101,831,675 | 882,500 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $74,664,821 | 701,803 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $56,843,568 | 512,335 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $84,267,300 | 978,487 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $51,600,761 | 565,984 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $71,333,531 | 869,391 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,534,639 | 20,024 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,504,002 | 20,024 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $30,088,746 | 386,894 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $21,998,028 | 285,355 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $16,103,671 | 194,137 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||